Misinformation regarding tandem mass spectrometric vs fluorometric assays to screen newborns for LSDs
Sign Up to like & getrecommendations! Published in 2017 at "Molecular Genetics and Metabolism Reports"
DOI: 10.1016/j.ymgmr.2017.04.009
Abstract: Sir – Newborn screening (NBS) programs are actively considering investment in one of two available platforms for multiple lysosomal storage disease (LSD) enzyme testing – tandem mass spectrometry (MS/MS) or digital microfluidic fluorometry (DMF) system.… read more here.
Keywords: regarding tandem; illinois; misinformation regarding; mass ... See more keywords